NCT06492174: An ongoing trial by Boston Scientific Corporation
This trial is ongoing. It must report results 8 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06492174 |
|---|---|
| Title | AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 7, 2024 |
| Completion date | Dec. 19, 2025 |
| Required reporting date | Dec. 19, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |